Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Market Cap	15.03B +2.9%
Revenue (ttm)	6.40B +1.7%
Net Income	923.00M +2.8%
EPS	18.37 +2.7%
Shares Out	50.25M
PE Ratio	16.27
Forward PE	23.11
Dividend	3.50 (1.17%)
Ex-Dividend Date	Dec 29, 2025

Volume	59,200
Average Volume	89,705
Open	299.00
Previous Close	298.00
Day's Range	298.00 - 302.00
52-Week Range	239.00 - 444.00
Beta	0.32
RSI	53.77
Earnings Date	May 15, 2026

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 220
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4574

Financial Performance

In 2025, Taiko Pharmaceutical's revenue was 6.40 billion, an increase of 1.67% compared to the previous year's 6.29 billion. Earnings were 923.00 million, an increase of 2.78%.